Toggle Health Problems and D


47 items in Calcidiol category

Calcidiol = Calcifediol = 25-hydroxyvitamin D3 = 25(OH)D = semi-activated Vitamin D
See also

Did you know?
  • Semi-activation is accomplished by enzymes: CYP2A1 in liver and/or CYP2R1 in cells
  • Calcidiol is also available as a drug, an herb, and from eggs and meat
  • Calcidiol become fully activated into Calcitriol by CYP27B1 enzymes in Kidney and/or tissues
          (More Calcidiol info below this box)

Learn how Vitamin D is essential for good health
  Watch a 5 minute video "Does Less Sun Mean more Disease?"
  Browse for other Health Problems and D in left column or here
  see also Supplementing and More in the menu at the top of every page
If you have a disease associated with low Vit D take Vit D
Raising your Vit D levels will substantially prevent other low-Vit D health problems
Proof that Vitamin D Works   Getting Vitamin D into your body

Is 50ng enough?   How to restore levels quickly  VitaminDWiki interview and transcript - Jan 2022
Books and Videos 265   Diseases that may be related via low vitamin D
Reasons for low response to vitamin D   Why are doctors reluctant
Cancer studies include:   Breast 253   Colon 141   Lung 55   Prostate 101   Pancreatic 56   Skin 121
Colds and flu   Dark Skin 464   Diabetes 543   Obesity 434   Pregnancy 901   Seniors 431
COVID-19 treated by Vitamin D - studies, reports, videos

in Visio for 2023
click on image for details

Getting Vitamin D into your body has the following chart


Here are all the Calcidiol articles

Calcidiol is available only by prescription and is expensive

Thirty 25ug capsules for $21
If you believe that calcidiol is 4X more potent than Vitamin D then each capsule has the equivalent of
   4,000 (4 X 40 X 25) IUs of vitamin D.
The cost of 4,000 IUs of vitamin D is about 2 cents
The cost of calcitriol is thus approximately 35 X more than Vitamin D3 (21/30)/0.02

Calcidiol - daily dose has fast response, but weekly might be better - March 2018

Correction of vitamin D status by calcidiol: pharmacokinetic profile, safety, and biochemical effects on bone and mineral metabolism of daily and weekly dosage regimens.
Osteoporos Int. 2017 Nov;28(11):3239-3249. doi: 10.1007/s00198-017-4180-3
Minisola S1, Cianferotti L2, Biondi P1, Cipriani C1, Fossi C2, Franceschelli F2, Giusti F2, Leoncini G2, Pepe J1, Bischoff-Ferrari HA3, Brandi ML4.

 Download the PDF from VitaminDWiki
Daily high dose raised blood levels quickly
FGF23 - similar large daily dose and weekly dose
1,25 similar response to all treatments
Least Calcium lost in Urine = weekly

RATIONALE: Calcidiol can be employed to correct vitamin D deficiency.

MAIN RESULTS: Calcidiol administered at daily and weekly regimens over a period of 3 months was able to successfully raise 25-hydroxyvitamin D levels without altering other markers related to bone and mineral metabolism.

SIGNIFICANCE: Calcidiol supplementation is effective and safe.

The correction of vitamin D status is necessary to maintain an optimal mineral and skeletal homeostasis. Despite cholecalciferol (vitamin D3) is the most commonly used drug for vitamin D supplementation, the more hydrophilic compound calcidiol (25-hydroxyvitamin D3) can be employed at daily, weekly, and monthly regimens to reach in the short term the target levels of serum 25-hydroxyvitamin D [25(OH)D]. In the administration of different doses of calcidiol pharmacokinetic study (ADDI-D study), the efficacy and safety of daily and weekly dosages of calcidiol were tested.

A total of 87 Caucasian, community-dwelling, postmenopausal women, aged 55 years or older, with vitamin D inadequacy (serum 25(OH)D levels <30 ng/ml, with mean 25(OH)D below 20 ng/ml, namely 16.5 ± 7.5 ng/ml) were randomized to receive three different dosages of calcidiol: 20 μg/day, 40 μg/day, and 125 μg/week for 3 months. The attained level of serum 25(OH)D was selected as primary endpoint to assess efficacy, while other parameters of mineral metabolism, (serum calcium, parathyroid hormone, phosphate, FGF23, urinary calcium, and markers of bone turnover) were assessed as secondary endpoints to establish safety.

In all the three groups, serum 25(OH)D values significantly and promptly rose and plateaued above the 30 ng/ml threshold remaining within safety interval after 14 days of treatment, with similar efficacy for the similar daily and weekly dose regimens. The different dosages were also equally effective in controlling secondary hyperparathyroidism. No significant changes in calcium and phosphate metabolism and in bone turnover markers were observed for any of the treatments, confirming the safety of this compound.

The results of this study demonstrate the short- and mid-term efficacy and safety on core parameters of mineral metabolism of different daily or weekly dosages of calcidiol when used to treat vitamin D inadequacy or deficiency in postmenopausal women. Further studies are needed to assess falls as primary outcome of calcidiol supplementation.

Created by admin. Last Modification: Thursday June 20, 2024 13:27:45 GMT-0000 by admin. (Version 67)
29012 visitors, last modified 20 Jun, 2024,
(Cached) Printer Friendly Follow this page for updates

Attached files

ID Name Comment Uploaded Size Downloads
15635 which is better - sci-hub.pdf admin 25 May, 2021 647.59 Kb 649
14958 map_pin_icon.png oregional 31 Jan, 2021 1.08 Kb 372
9487 Caclium in urine.jpg admin 10 Mar, 2018 19.71 Kb 2881
9485 calcidiol 1,25 daily weekl.jpg admin 10 Mar, 2018 14.36 Kb 2924
9483 calcidiol daily weekl.jpg admin 10 Mar, 2018 32.22 Kb 3229
9482 Calcidiol FGF23.jpg admin 10 Mar, 2018 14.29 Kb 2935
9481 calcidiol daily weekly.pdf admin 10 Mar, 2018 921.11 Kb 1541